VNSE
Natixis Vaughan Nelson Select ETF
S&P 500 TR USD
NAV as of
4 Week: 27.84 - 28.46
52 Week: 23.24 - 28.46
Latest Closing Price
28.45
Premium / Discount
-0.04
Expense Ratio
0.8%
Investment Objective
The investment seeks long-term capital appreciation. The fund, under normal market conditions, will invest primarily in equity securities, including exchange-traded common stocks, exchange-traded preferred stocks and exchange-traded real estate investment trusts ("REITs"). Typically, its portfolio will generally hold 20 to 40 securities. The fund may invest in companies with any market capitalization, although, it will typically focus its investments in mid- to large- capitalization companies. It is non-diversified.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | 13.16 | 0.87 | 15.09 |
| 1 Day | 1.29 | 0.00 | 0.00 |
| 1 Week | 0.08 | 2.44 | 0.03 |
| 1 Month | 4.25 | 3.23 | 1.32 |
| 3 Months | 10.25 | 6.35 | 1.61 |
| 6 Months | 8.08 | 10.74 | 0.75 |
| 1 Year | 8.40 | 19.71 | 0.43 |
| 2 Years | -9.35 | 32.45 | -0.29 |
| 3 Years | 0.00 | 0.00 | 0.00 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 38.4972 | -16.5925 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 2.0000 | 38.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| N.A | ||
Portfolio Data
Total Number of Holdings: 29
Number of Bond Holdings: 0
Number of Equity Holdings: 28
Total Market Value: 20,950,464
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Inc | 5.8243 | 2,149 | 494 | 602,601 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 30.34 |
| Large | 40.54 |
| Medium | 20.37 |
| Small | 5.76 |
| Micro | 0.00 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
24.4834
Price/Book*
4.2923
Price/Sales*
3.7578
Price/Cash Flow*
14.9064
Dividend Yield*
1.2858
Growth Measures
Long-Term Earnings
11.0705
Historical Earnings
15.9233
Sales Growth
12.1933
Cash-Flow Growth
8.4708
Book-Value Growth
8.9866
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
